FdaApplication
ANDA 203503
Identifiers
- fda_app_no: ANDA203503
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2015-09-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VORICONAZOLE | VORICONAZOLE | 50MG | TABLET;ORAL |
| VORICONAZOLE | VORICONAZOLE | 200MG | TABLET;ORAL |
2 products